Zevra therapeutics to participate at upcoming investor conferences

Celebration, fla., jan. 29, 2025 (globe newswire) -- zevra therapeutics, inc. (nasdaqgs: zvra) (zevra, or the company), a commercial-stage rare disease therapeutics company, today announced that members of zevra's executive leadership team will participate in the following february events.
ZVRA Ratings Summary
ZVRA Quant Ranking